Evaluation of Biomarkers for Prediction of Morbidity and Mortality in COVID-19 at a Tertiary Care Center in Pakistan

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042375

Enrollment

Unknown

Registered

2021-01-21

Start date

2020-03-01

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Severe COVID:Nil

non-severe COVID:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: both genders and aged >=18 years old groups with SARS-CoV-2 positive on a reverse-transcriptase polymerase chain reaction (PCR) test and received treatment at our center.

Exclusion criteria

Exclusion criteria: 1) biochemical work up on admission not undertaken; 2) known thalassemic cases.

Design outcomes

Primary

Measure	Time frame
Prognosis;	—

Countries

Pakistan

Contacts

Public ContactDr Sibtain Ahmed

Aga Khan University

sibtain.ahmed@gmail.com+922134861951

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026